vs
Side-by-side financial comparison of Primis Financial Corp. (FRST) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $45.6M, roughly 1.6× Primis Financial Corp.). Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs -34.4%).
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
FRST vs MED — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.6M | $75.1M |
| Net Profit | $7.3M | — |
| Gross Margin | — | 69.4% |
| Operating Margin | — | -10.4% |
| Net Margin | 16.0% | — |
| Revenue YoY | — | -36.9% |
| Net Profit YoY | 200.0% | — |
| EPS (diluted) | $0.30 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $75.1M | ||
| Q3 25 | $41.0M | $89.4M | ||
| Q2 25 | $43.2M | $105.6M | ||
| Q1 25 | $58.7M | $115.7M | ||
| Q4 24 | $38.8M | $119.0M | ||
| Q3 24 | $37.3M | $140.2M | ||
| Q2 24 | $35.7M | $168.6M |
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | — | ||
| Q3 25 | $6.8M | $-2.3M | ||
| Q2 25 | $2.4M | $2.5M | ||
| Q1 25 | $22.6M | $-772.0K | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $1.2M | $1.1M | ||
| Q2 24 | $3.4M | $-8.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 73.2% |
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | -10.4% | ||
| Q3 25 | 21.3% | -4.6% | ||
| Q2 25 | 6.9% | -1.0% | ||
| Q1 25 | 41.9% | -1.1% | ||
| Q4 24 | -123.0% | 0.6% | ||
| Q3 24 | -3.1% | 1.5% | ||
| Q2 24 | 7.8% | -4.7% |
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 16.7% | -2.5% | ||
| Q2 25 | 5.6% | 2.3% | ||
| Q1 25 | 38.6% | -0.7% | ||
| Q4 24 | -100.3% | — | ||
| Q3 24 | 3.3% | 0.8% | ||
| Q2 24 | 9.6% | -4.8% |
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $-1.64 | ||
| Q3 25 | $0.28 | $-0.21 | ||
| Q2 25 | $0.10 | $0.22 | ||
| Q1 25 | $0.92 | $-0.07 | ||
| Q4 24 | $-0.95 | $0.08 | ||
| Q3 24 | $0.05 | $0.10 | ||
| Q2 24 | $0.14 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.9M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $427.2M | $198.9M |
| Total Assets | $4.3B | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $167.3M | ||
| Q3 25 | $63.9M | $173.5M | ||
| Q2 25 | $94.1M | $162.7M | ||
| Q1 25 | $57.0M | $164.6M | ||
| Q4 24 | $64.5M | $162.3M | ||
| Q3 24 | $77.3M | $170.0M | ||
| Q2 24 | $66.6M | $163.5M |
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $198.9M | ||
| Q3 25 | $382.2M | $214.7M | ||
| Q2 25 | $376.4M | $216.0M | ||
| Q1 25 | $375.6M | $211.0M | ||
| Q4 24 | $351.8M | $210.1M | ||
| Q3 24 | $381.0M | $207.3M | ||
| Q2 24 | $376.0M | $205.3M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $248.0M | ||
| Q3 25 | $4.0B | $268.2M | ||
| Q2 25 | $3.9B | $269.3M | ||
| Q1 25 | $3.7B | $280.0M | ||
| Q4 24 | $3.7B | $284.2M | ||
| Q3 24 | $4.0B | $291.2M | ||
| Q2 24 | $4.0B | $293.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $-5.3M | ||
| Q3 25 | $-11.4M | $12.1M | ||
| Q2 25 | $-41.0M | $-3.4M | ||
| Q1 25 | $34.4M | $3.4M | ||
| Q4 24 | $19.5M | $-4.9M | ||
| Q3 24 | $6.1M | $9.1M | ||
| Q2 24 | $52.3M | $13.1M |
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | $-6.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | $18.3M | $-7.2M | ||
| Q3 24 | — | $7.7M | ||
| Q2 24 | — | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | -8.8% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | -4.5% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | 47.3% | -6.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 3.1% | 1.9% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 0.0% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | — | ||
| Q3 25 | -1.67× | — | ||
| Q2 25 | -16.82× | -1.36× | ||
| Q1 25 | 1.52× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.93× | 8.04× | ||
| Q2 24 | 15.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
MED
Segment breakdown not available.
